About: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.20 (+2.14%)
CRDL NASDAQ Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc Class A share price
Atividade de preço de CRDL
Último preço
$ 1,190
Variação (24h)
0,02 USD (1,71%)
Volume
185.24K
Volume (média 4 sem.)
-
Abertura
$ 1,18
Variação do dia
$ 1,18 - $ 1,22
Fechamento anterior
$ 1,17
Último negócio
29 Oct, 3:05 pm GMT+0
Atrasado
29 Oct, 3:05 pm GMT+0
CRDL price performance
Atrasado
29 Oct, 3:05 pm GMT+0
quote.marketSignals